Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TNeuroPharma
AddedFeb 17, 2024
UpdatedJun 18, 2026
TNeuroPharma

TNeuroPharma

Angel

TNeuroPharma: Innovating T-cell tech for early Alzheimer's detection and treatment, based in New Mexico.

HQ
Albuquerque, NM, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in 2018 and based in Albuquerque, New Mexico, TNeuroPharma focuses on developing therapeutic-based technology targeting T-cell contributions to track and treat neurodegenerative diseases. The company's core mission is to enable early detection and treatment of Alzheimer's disease through innovative T-cell technology. Their primary product, the T-Track Biomarker, uses blood samples to identify dysfunctional T-cells, allowing for early diagnosis and intervention, which can prevent further complications and improve patient outcomes.

TNeuroPharma has garnered attention for its cutting-edge approach to Alzheimer's detection. While specific notable affiliated people and investors are not mentioned, the company's impact is significant in the field of neurodegenerative disease research. By providing a method for early detection, TNeuroPharma aims to revolutionize how Alzheimer's is diagnosed and treated, potentially altering the disease's trajectory and improving the quality of life for countless patients.

TNeuroPharma - Similar Companies

Neurotrack logo

Neurotrack

neurotrack.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

NeurInsight logo

NeurInsight

neurinsight.com

T3D Therapeutics logo

T3D Therapeutics

Neuraly logo

Neuraly

neuralymed.com

Alzeca Biosciences logo

Alzeca Biosciences

alzeca.com

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Neuropore Therapies logo

Neuropore Therapies

neuropore.com

TheraCea Pharma logo

TheraCea Pharma

theracea.com

NeuroX1 logo

NeuroX1

neurox1.com

NeurOp logo

NeurOp

Neuro42 logo

Neuro42

NeurAegis logo

NeurAegis

neuraegis.com

Alto Neuroscience logo

Alto Neuroscience

TNeuroPharma - Quick Facts

Who are TNeuroPharma's competitors?

Companies similar to TNeuroPharma include Neurotrack, NeuroGenetic Pharmaceuticals, NeurInsight and T3D Therapeutics.

When was TNeuroPharma founded?

TNeuroPharma was founded in 2018.

Where is TNeuroPharma's headquarters located?

TNeuroPharma's headquarters is located in Albuquerque, NM, US.

When was TNeuroPharma's last funding round?

TNeuroPharma's most recent funding round was for $25k (USD) in March 2022.

How much has TNeuroPharma raised to-date?

As of Mar 31, 2022, TNeuroPharma has raised a total of $25k (USD).

How many employees does TNeuroPharma have?

TNeuroPharma has 5 employees as of Feb 4, 2024.

TNeuroPharma - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotech
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research